Mauro Zaffaroni

6.9k total citations
130 papers, 3.4k citations indexed

About

Mauro Zaffaroni is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Mauro Zaffaroni has authored 130 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Pathology and Forensic Medicine, 32 papers in Neurology and 27 papers in Immunology. Recurrent topics in Mauro Zaffaroni's work include Multiple Sclerosis Research Studies (75 papers), Peripheral Neuropathies and Disorders (25 papers) and Systemic Lupus Erythematosus Research (12 papers). Mauro Zaffaroni is often cited by papers focused on Multiple Sclerosis Research Studies (75 papers), Peripheral Neuropathies and Disorders (25 papers) and Systemic Lupus Erythematosus Research (12 papers). Mauro Zaffaroni collaborates with scholars based in Italy, United States and United Kingdom. Mauro Zaffaroni's co-authors include Angelo Ghezzi, Gıancarlo Comı, E. Verdun, Luca Durelli, Maria Giovanna Marrosu, Vittorio Martinelli, Carlo Pozzilli, Enrico Montanari, Mauro Bergui and Elisabetta Versino and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mauro Zaffaroni

127 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mauro Zaffaroni Italy 33 2.3k 1.1k 700 554 553 130 3.4k
Vesna Brinar Croatia 22 2.6k 1.2× 1.2k 1.1× 781 1.1× 600 1.1× 576 1.0× 99 3.5k
John R. Corboy United States 32 2.3k 1.0× 1.1k 1.0× 628 0.9× 527 1.0× 730 1.3× 110 3.9k
Douglas Jeffery United States 26 2.7k 1.2× 1.2k 1.1× 761 1.1× 768 1.4× 560 1.0× 84 3.7k
Aaron Miller United States 31 2.9k 1.3× 1.2k 1.1× 952 1.4× 676 1.2× 604 1.1× 119 4.0k
Omar Khan United States 33 2.1k 0.9× 917 0.8× 599 0.9× 950 1.7× 715 1.3× 87 3.9k
Daniel Wynn United States 26 2.7k 1.2× 1.1k 1.0× 653 0.9× 1.0k 1.8× 792 1.4× 50 3.6k
Melinda Magyari Denmark 35 2.7k 1.2× 865 0.8× 587 0.8× 478 0.9× 559 1.0× 181 3.6k
Magnus Vrethem Sweden 30 1.3k 0.6× 970 0.9× 332 0.5× 474 0.9× 541 1.0× 108 3.0k
Lucia Moiola Italy 40 3.6k 1.6× 1.8k 1.6× 811 1.2× 789 1.4× 658 1.2× 160 4.9k
Jelena Drulović Serbia 37 3.2k 1.4× 1.2k 1.1× 929 1.3× 432 0.8× 752 1.4× 174 4.7k

Countries citing papers authored by Mauro Zaffaroni

Since Specialization
Citations

This map shows the geographic impact of Mauro Zaffaroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Zaffaroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Zaffaroni more than expected).

Fields of papers citing papers by Mauro Zaffaroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauro Zaffaroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Zaffaroni. The network helps show where Mauro Zaffaroni may publish in the future.

Co-authorship network of co-authors of Mauro Zaffaroni

This figure shows the co-authorship network connecting the top 25 collaborators of Mauro Zaffaroni. A scholar is included among the top collaborators of Mauro Zaffaroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauro Zaffaroni. Mauro Zaffaroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mallucci, Giulia, Ottavia Eleonora Ferraro, María Trojano, et al.. (2024). Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score. Journal of Neurology. 271(6). 3496–3505.
2.
Lazzaro, Carlo, Roberto Bergamaschi, Mauro Zaffaroni, Rocco Totaro, & Damiano Paolicelli. (2022). Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing–remitting multiple sclerosis in Italy. Neurological Sciences. 43(8). 4933–4944. 2 indexed citations
3.
Signoriello, Elisabetta, Giacomo Lus, Simona Bonavita, et al.. (2021). Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy. Multiple Sclerosis Journal. 28(1). 93–101. 13 indexed citations
4.
Baroncini, Damiano, Angelo Ghezzi, Pietro Annovazzi, et al.. (2016). Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies. Multiple Sclerosis Journal. 22(10). 1315–1326. 55 indexed citations
5.
Serana, Federico, Luisa Imberti, Maria Pia Amato, et al.. (2014). MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients. PLoS ONE. 9(4). e94794–e94794. 15 indexed citations
6.
Cosentino, Marco, Mauro Zaffaroni, María Trojano, et al.. (2012). Dopaminergic Modulation of CD4+CD25<sup>high</sup> Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy. NeuroImmunoModulation. 19(5). 283–292. 39 indexed citations
7.
Berto, Patrizia, Maria Pia Amato, P. Bellantonio, et al.. (2011). The direct cost of patients with multiple sclerosis: a survey from Italian MS centres. Neurological Sciences. 32(6). 1035–1041. 20 indexed citations
8.
Gironi, M., Filippo Martinelli Boneschi, Paola Sacerdote, et al.. (2008). A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Multiple Sclerosis Journal. 14(8). 1076–1083. 66 indexed citations
9.
Zaffaroni, Mauro, et al.. (2008). Induction and add-on therapy with Mitoxantrone and Interferon beta in multiple sclerosis. Neurological Sciences. 29(S2). 230–232. 7 indexed citations
10.
Zaffaroni, Mauro, Franca Marino, R Bombelli, et al.. (2008). Therapy with interferon-β modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis. Experimental Neurology. 214(2). 315–321. 47 indexed citations
11.
Ghezzi, Angelo, Maria Pia Amato, Marco Capobianco, et al.. (2005). Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Multiple Sclerosis Journal. 11(4). 420–424. 77 indexed citations
12.
Zaffaroni, Mauro. (2005). Treatment optimisation in multiple sclerosis. Neurological Sciences. 26(S4). s187–s192. 8 indexed citations
13.
Verdun, E., G. Isoardo, Alessandra Oggero, et al.. (2002). Autoantibodies in Multiple Sclerosis Patients Before and During IFN- β 1b Treatment: Are They Correlated with the Occurrence of Autoimmune Diseases?. Journal of Interferon & Cytokine Research. 22(2). 245–255. 27 indexed citations
14.
Dario, Alessandro, et al.. (2002). Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion.. PubMed. 16(4). 311–5. 22 indexed citations
15.
Ghezzi, Angelo, Vittorio Martinelli, Valter Torri, et al.. (1999). Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. Journal of Neurology. 246(9). 770–775. 73 indexed citations
16.
Bona, Gianni, et al.. (1992). Effects of iopamidol on neonatal thyroid function. European Journal of Radiology. 14(1). 22–25. 18 indexed citations
17.
Zaffaroni, Mauro, et al.. (1989). Thyroid and growth: thyroid hormones and development of the nervous system.. PubMed. 12(8 Suppl 3). 85–9. 4 indexed citations
18.
Ghezzi, Angelo, et al.. (1985). Lymphocytoplasmapheresis in multiple sclerosis: preliminary laboratory findings. Neurological Sciences. 6(1). 85–87. 4 indexed citations
19.
Zaffaroni, Mauro, et al.. (1984). Monoclonal antibody analysis of blood T-cell subsets in multiple sclerosis. Neurological Sciences. 5(1). 45–50. 7 indexed citations
20.
Caputo, Domenico, Angelo Ghezzi, Mauro Zaffaroni, & A. Zibetti. (1982). Polyneuritic onset in multiple sclerosis. Neurological Sciences. 3(4). 355–357. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vesna Brinar Breakdown of academic impact, for papers by John R. Corboy Breakdown of academic impact, for papers by Douglas Jeffery Breakdown of academic impact, for papers by Aaron Miller Breakdown of academic impact, for papers by Omar Khan Breakdown of academic impact, for papers by Daniel Wynn Breakdown of academic impact, for papers by Melinda Magyari Breakdown of academic impact, for papers by Magnus Vrethem Breakdown of academic impact, for papers by Lucia Moiola Breakdown of academic impact, for papers by Jelena Drulović
Rankless by CCL
2026